
Humacyte, Inc.
Humacyte, Inc.(HUMA)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
huma · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$10.00
Consensus
$5.58
+305.8% upside
Low
$3.00
Median: $5.5 · Last Close: $1.38
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$5.58
305.8% upside
High Target
$10
627.3%
Low Target
$3
118.2%
Current Price
$1.38
as of today
Based on analyst price targets, the HUMA stock price prediction for the next 12 months ranges from $3 to $10. The consensus HUMA price forecast of $5.58 implies 305.8% upside from the current price of $1.38.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.44 | ↑ 5.00% |
1-day model range: $1.42–$1.47. Peak: $1.47 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -34.7% |
| 2028 | $1 | -46.1% |
| 2029 | $1 | -50.7% |
| 2030 | $1 | -52.9% |
| 2031 | — | -53.9% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HUMA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2026-05-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | TD Cowen | Maintains | Buy→Buy |
| 2026-05-13 | BTIG | Maintains | Buy→Buy |
| 2026-04-28 | BTIG | Maintains | Buy→Buy |
| 2026-04-28 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-04-24 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-04-21 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-04-08 | Barclays | Maintains | Overweight→Overweight |
| 2026-03-31 | Benchmark | Maintains | Buy→Speculative Buy |
Wall Street analysts have recently issued updated ratings on Humacyte, Inc. (HUMA) stock. Of the recent 91 rating actions, 0 were upgrades and 0 were downgrades. 11 analysts currently cover HUMA.
分析师推荐趋势
HUMA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$6M
↓ 94.1% YoY
Revenue Next Year
$25M
↑ 282.3% YoY
EPS This Year
$-0.36
EPS Next Year
$-0.30
↓ 16.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast HUMA EPS of $-0.36 for the current fiscal year, based on estimates from 3 analysts. The HUMA revenue forecast is $6M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
HUMA 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。HUMA 的共识目标价为 $5.58(+305.8% 上行空间),分析师共识为 Buy。
HUMA 的短期预测(明日)为 $1.44(+5.00%)。 HUMA 对 2027 年的股价预测均值为 $1。 HUMA 对 2030 年的预测区间为 $1–$1。
Humacyte, Inc. 在 NASDAQ 上市,代码 HUMA。HUMA 在 2027 年的整体展望偏积极,在覆盖分析师中约 91% 对应 Buy 共识。
常见问题
HUMA 预测 · 8 个问题根据 11 位华尔街分析师,HUMA 的 12 个月平均目标价为 $5.58,最高 $10.00、最低 $3.00。若有图表,中位目标价可在上方查看。相对当前价 $1.38,隐含约 +305.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.